Correlation of PIM kinases with tumor immune microenvironment and clinical presentation of metastatic hormone-sensitive prostate cancer.

被引：0
|
作者：
Recio-Boiles, Alejandro
Clements, Amber N.
Deshmukh, Sachin Kumar
Bertolo, Aaron
Estrada-Mendizabal, Ricardo J.
Saboda, Kathylynn
Wu, Sharon
Xiu, Joanne
Radovich, Milan
Sutterby, Kai
Chauhan, Shailender S.
McKay, Rana R.
Nabhan, Chadi
Warfel, Noel A.
机构：
[1] Univ Arizona, Canc Ctr, Tucson, AZ USA
[2] Caris Life Sci, Phoenix, AZ USA
[3] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Mexico
[4] Univ Calif San Diego, La Jolla, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
D O I：
10.1200/JCO.2024.42.4_suppl.211
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
211
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [41] Triplet Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer
    Hindie, Elif
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (22) : 3873 - 3875
  • [42] Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
    Olivier, Timothee
    Tsantoulis, Petros
    Prasad, Vinay
    EUROPEAN UROLOGY, 2023, 83 (06) : 584 - 585
  • [43] Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer
    Ajjai Alva
    Maha Hussain
    Drugs, 2013, 73 : 1517 - 1524
  • [44] Metastatic hormone-sensitive prostate cancer: How should it be treated?
    Lopez-Campos, Fernando
    Gonzalez-San Segundo, Carmen
    Conde-Moreno, Antonio Jose
    Counago, Felipe
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (02): : 43 - 49
  • [45] Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
    Mathieu, Romain
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY, 2016, 69 (04) : 755 - 756
  • [46] Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer
    Chen, Kenneth
    McVey, Aoife
    Kasivisvanathan, Veeru
    Jenjitranant, Pocharapong
    Azad, Arun
    Murphy, Declan G.
    EUROPEAN UROLOGY, 2022, 82 (01) : 146 - 147
  • [47] Estrogen receptor β and TMPRSS2-ERG expression association with clinical outcomes in metastatic hormone-sensitive prostate cancer.
    Aversa, Caterina
    Enez, Natalia Jim .
    Marin, Mercedes
    Ferrer-Mileo, Laura
    Reig, Oscar
    Rodriguez-Carunchio, Leonardo
    Font, Albert
    Rodriguez-Vida, Alejo
    Domenech-Santasusana, Montserrat
    Figols, Mariona
    Duran, Miguel Angel Climent
    Costa, Sara Cros
    Chirivella, Isabel
    Rivera, Daniel Herrero
    Gonzalez-Billalabeitia, Enrique
    Enez-Peralta, Daniel Jim
    Carles, Joan
    Suarez, Cristina
    Prat, Aleix
    Mellado, Begona
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [48] Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer
    Wala, Jeremiah
    Nguyen, Paul
    Pomerantz, Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (20) : 3584 - +
  • [49] Correction to: Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
    Arnold Lee
    Targeted Oncology, 2023, 18 (5) : 801 - 801
  • [50] Optimal Pharmacotherapeutic Management of Hormone-Sensitive Metastatic Prostate Cancer
    Alva, Ajjai
    Hussain, Maha
    DRUGS, 2013, 73 (14) : 1517 - 1524
12345